The News
The News
Tuesday 24 of May 2022

PRI urges the health sector to end drug shortages


No disponible
No disponible
In the Chamber of Deputies, the Institutional Revolutionary Party (PRI) urges the health sector to end the shortage of medicines.

The parliamentary faction of the PRI in the Chamber of Deputies urged government authorities to establish mechanisms to resolve the serious shortage problem that persists in clinics and hospitals in the health sector throughout the country.

The legislator Xavier González Zirión pointed out the need for the acquisition, delivery and distribution of medical supplies and drugs to be normalized, to end the serious consequences that patients who come to the public health sector have suffered, for the health systems themselves and for society in general.

To show the dimension of the problem, the federal deputy mentioned the data from the Pharmaceutical Research and Innovation Institute (INEFAM), from the 2018 tender, which was the last one chaired by the Mexican Social Security Institute (IMSS).

I specify that in 2019, 332 million 652 thousand pieces of medicine and healing material were purchased, compared to only 180 million 533 thousand pieces in the same period of 2021, this represents a decrease of 46 percent.
He indicated that, in addition to buying half of what is necessary, today only 4 distributors were hired at the national level, against the more than 20 that were before, which, he stressed, saturates distribution and makes supplies take longer to arrive. to the patient.

For this reason, González Zirión urged the Ministry of Health, the Mexican Institute of Social Security (IMSS), the Institute of Security and Social Services for State Workers (ISSSTE), and the Institute of Health for Well-being (Insabi), to , within the framework of its attributions and with the experience of Social Security to bid, the supply and distribution of the inputs that still persist today be resolved.

Finally, the PRI called for the Ministry of Finance to speed up this process, in a more efficient way, in the supervision of the tenders and purchases carried out by the IMSS and other institutions to guarantee that they are free of corruption.